Impacts of age and gender at the risk of underlying medical conditions and death in patients with avian influenza A (H7N9): a meta-analysis study
- PMID: 30233197
- PMCID: PMC6132488
- DOI: 10.2147/TCRM.S173834
Impacts of age and gender at the risk of underlying medical conditions and death in patients with avian influenza A (H7N9): a meta-analysis study
Abstract
Objective: The objective of our study was to conduct a series of analyses that examined the impacts of age and gender at the risk of underlying medical conditions (UMCs) and death in patients with influenza A (H7N9).
Methods: We began by searching for potentially relevant articles in English or Chinese before February 28, 2018. Additionally, we reviewed our own files and reference lists of articles identified by this search.
Results: The association between death and UMCs was significant in H7N9 patients, with an OR of 1.49 (95% CI: 1.24-1.78). Subgroup analyses showed that having two or more UMCs of any type (OR: 2.24; P=0.044), chronic respiratory diseases (OR: 1.81; P=0.032), and chronic cardiovascular disease (OR: 1.63; P=0.013) had an association with increased fatality in H7N9 patients. Age (60 years or older) [adjusted OR (AOR): 1.86; P=0.032] and gender (male: AOR: 1.68, P=0.006; female: AOR: 1.88, P=0.044) were significantly associated with death in H7N9 patients with UMCs compared to H7N9 patients without any UMC. Stratification analyses found statistically significant increased death in H7N9 patients with UMCs who were 60 years of age and older (AOR: 2.72; P<0.001) and gender (male; AOR=1.64; P=0.033), compared to H7N9 patients without these respective conditions.
Conclusion: Impacts of age are substantial and significant at the risk of UMCs and death in H7N9 patients. This analysis did not find a significant difference in gender comparisons. Efforts should particularly focus on reducing fatality rates in patients with combined risks from UMCs and other significant impact factor such as age (60 years or older).
Keywords: H7N9; avian influenza virus; fatality; meta-analysis; underlying medical conditions.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures







Similar articles
-
Influenza-associated hospitalization rates by underlying conditions, 2016-17 to 2019-20: A retrospective cohort study.J Infect Dis. 2025 Mar 28:jiaf164. doi: 10.1093/infdis/jiaf164. Online ahead of print. J Infect Dis. 2025. PMID: 40155312
-
[Design and application of bundle treatment plan in the early stage for severe human infection by avian influenza H7N9].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Jan;30(1):24-28. doi: 10.3760/cma.j.issn.2095-4352.2018.01.005. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018. PMID: 29308753 Chinese.
-
Retrospective study of risk factors for mortality in human avian influenza A(H7N9) cases in Zhejiang Province, China, March 2013 to June 2014.Int J Infect Dis. 2015 Oct;39:95-101. doi: 10.1016/j.ijid.2015.09.008. Epub 2015 Sep 14. Int J Infect Dis. 2015. PMID: 26376223
-
Avian influenza A (H7N9) virus infection in humans: epidemiology, evolution, and pathogenesis.Infect Genet Evol. 2014 Dec;28:304-12. doi: 10.1016/j.meegid.2014.10.016. Epub 2014 Oct 24. Infect Genet Evol. 2014. PMID: 25446940 Review.
-
Seroprevalence of H7N9 infection among humans: A systematic review and meta-analysis.Influenza Other Respir Viruses. 2020 Sep;14(5):587-595. doi: 10.1111/irv.12736. Epub 2020 Mar 10. Influenza Other Respir Viruses. 2020. PMID: 32157809 Free PMC article.
References
-
- Zhang F, Bi Y, Wang J, et al. Human infections with recently-emerging highly pathogenic H7N9 avian influenza virus in China. J Infect. 2017;75(1):71–75. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources